Skip to content
Ubiquitin Ligase-ubiquitin-ligase.com
  • Home
  • About US
  • Search Search

Category: Uncategorized

Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)synonym : null,productDescription : Farletuzumab-MMAE is...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-FOLH1 / PSMA Reference Antibody (rosopatamab tetraxetan)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-FOLH1 / PSMA Reference Antibody (rosopatamab tetraxetan)synonym : null,productDescription : Rosopatamab...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-FOLH1 / PSMA Reference Antibody (rosopatamab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time59 sec read
Product Name : Anti-FOLH1 / PSMA Reference Antibody (rosopatamab-MMAE)synonym : null,productDescription : Rosopatamab-MMAE is...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time58 sec read
Product Name : Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE)synonym : null,productDescription :...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab mertansine)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time59 sec read
Product Name : Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab mertansine)synonym : null,productDescription : Lorvotuzumab...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time57 sec read
Product Name : Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab-MMAE)synonym : null,productDescription : Lorvotuzumab-MMAE is...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-Mesothelin Reference Antibody (anetumab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time57 sec read
Product Name : Anti-Mesothelin Reference Antibody (anetumab-MMAE)synonym : productDescription : Anetumab-MMAE is an ADC...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time59 sec read
Product Name : Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine)synonym : null,productDescription...
Post Categories Uncategorized
Post dateMay 17, 2024Post last updated dateUpdated May 17, 2024

Anti-Mesothelin Reference Antibody (anetumab ravtansine)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time57 sec read
Product Name : Anti-Mesothelin Reference Antibody (anetumab ravtansine)synonym : null,productDescription : Anetumab ravtansine is...
Post Categories Uncategorized
Post dateMay 16, 2024Post last updated dateUpdated May 16, 2024

Anti-CEACAM5 / CEA / CD66e Reference Antibody (Tusamitamab-MMAE)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time59 sec read
Product Name : Anti-CEACAM5 / CEA / CD66e Reference Antibody (Tusamitamab-MMAE)synonym : productDescription :...

Posts navigation

« 1 … 83 84 85 86 87 … 585 »

Recent Posts

  • Anti-MUC1 Reference Antibody (gatipotuzumab)
  • Anti-ERBB2 / HER2 / CD340 Reference Antibody (gancotamab)
  • Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4)
  • Anti-PCSK9 Reference Antibody (frovocimab)
  • Anti-TGFb1 Reference Antibody (fresolimumab)

Recent Comments

    Archives

    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Designed by Nasio Themes || Powered by WordPress